Search Results - "Giacinto Calculli"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Uric acid: from a biological advantage to a potential danger. A focus on cardiovascular effects by Cortese, Francesca, Giordano, Paola, Scicchitano, Pietro, Faienza, Maria Felicia, De Pergola, Giovanni, Calculli, Giacinto, Meliota, Giovanni, Ciccone, Marco Matteo

    Published in Vascular pharmacology (01-09-2019)
    “…Non-communicable diseases represent nowadays the most common cause of death worldwide, having largely overcome infectious diseases. Among them, cardiovascular…”
    Get full text
    Journal Article
  2. 2

    Uric Acid in Metabolic and Cerebrovascular Disorders: A Review by Cortese, Francesca, Scicchitano, Pietro, Cortese, Anna M, Meliota, Giovanni, Andriani, Andrea, Truncellito, Luigi, Calculli, Giacinto, Giordano, Paola, Ciccone, Marco M

    Published in Current vascular pharmacology (01-01-2020)
    “…Several studies showed a close link between metabolic syndrome (MetS), type 2 diabetes (T2DM) and cerebrovascular diseases. There is considerable debate…”
    Get more information
    Journal Article
  3. 3

    Idarucizumab: What Should We Know? by Cortese, Francesca, Calculli, Giacinto, Gesualdo, Michele, Cecere, Annagrazia, Zito, Annapaola, De Vito, Fiorella, Carbonara, Rossella, Carbonara, Santa, Cortese, Anna Maria, Ciccone, Marco Matteo

    Published in Current drug targets (01-01-2018)
    “…Idarucizumab, a humanized monoclonal antibody fragment acting as a specific antidote for dabigatran, is approved for reversing the dabigatran-associated…”
    Get more information
    Journal Article
  4. 4

    A Pathognomonic Case of Isolated Acute Right Ventricular Infarction by Francesca Cortese, Marco Matteo Ciccone, Michele Clemente, Giacinto Calculli

    Published in ICF journal (06-02-2019)
    “…Highlights Isolated right ventricular infarction occurs only in about 3% of the overall myocardial ischemic episodes. Clinical presentation is often insidious…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10